OPTAMI (Optimized Therapy of Acute Myocardial Infarction)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3248 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-10-31

Study Completion Date

2010-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

OPTAMI documents the characteristics of consecutive patients with acute STEMI and NSTEMI in hospital everyday-life in Germany, their acute and adjuvant medication treatment, events until discharge (e.g. mortality, stroke, re-MI), and their medication for secondary prevention at discharge.

In the follow up-period of one year, information is collected concerning events as mortality, stroke, re-MI, coronary interventions (PCI, CABG) and re-hospitalisation.

The implementation of guideline-adjusted therapy in hospital everyday-life is reviewed. The usefulness of the European standard for data acquisition in cardiology (CARDS = Cardiology Audit and Registration Standards) is evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction ST-Elevation Myocardial Infarction Non-ST-Elevation Myocardial Infarction

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Myocardial infarction ST-Elevation myocardial infarction Non-ST-Elevation myocardial infarction Register CARDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

STEMI

(ST-Elevation myocardial infarction)

No interventions assigned to this group

NSTEMI

Non-ST-Elevation myocardial infarction

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients admitted to hospital with an acute ST-Elevation myocardial infarction or with an acute Non-ST-Elevation myocardial infarction, both not older than 24 h

Exclusion Criteria

* missing informed consent

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anselm K Gitt, MD

Role: STUDY_CHAIR

Stiftung Institut für Herzinfarktforschung

Jochen Senges, MD

Role: STUDY_CHAIR

Stiftung Institut für Herzinfarktforschung

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medizinische Klinik und Poliklinik, Universitätklinikum Münster

Münster, , Germany

Site Status

Klinikum Nürnberg Süd / Cardiology

Nuremberg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OPTAMI

Identifier Type: -

Identifier Source: org_study_id

OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry